Yinghan L. Su
12 Urumqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
mTOR-driven integrin β4-enriched extracellular vesicles from lenvatinib-resistant hepatocellular carcinoma fuel lung metastasis via fibroblast-niche formation.
Journal: Signal transduction and targeted therapy
Published: August 17, 2025
Transforming acidic coiled-coil-containing protein 3-mediated lipid metabolism reprogramming impairs CD8+ T-cell cytotoxicity in hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: April 07, 2025
Multicenter evaluation of the diagnostic efficacy of jaundice color card for neonatal hyperbilirubinemia
Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics
Published: May 19, 2024
Current landscape and perspective of oncolytic viruses and their combination therapies.
Journal: Translational oncology
Published: May 14, 2022
Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors.
Journal: Journal for immunotherapy of cancer
Published: May 02, 2022
Emerging Regulatory Mechanisms of N6-Methyladenosine Modification in Cancer Metastasis.
Journal: Phenomics (Cham, Switzerland)
Published: August 15, 2021
Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 03, 2020
Tumor-Infiltrating T Cells Concurrently Overexpress CD200R with Immune Checkpoints PD-1, CTLA-4, and TIM-3 in Non-Small-Cell Lung Cancer.
Journal: Pathobiology : journal of immunopathology, molecular and cellular biology
Published: August 19, 2020
Uptake of collagen type I via macropinocytosis cause mTOR activation and anti-cancer drug resistance.
Journal: Biochemical and biophysical research communications
Published: February 26, 2020
An Artificially Designed Interfering lncRNA Expressed by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma.
Journal: Molecular cancer therapeutics
Published: February 20, 2016
Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
Journal: Oncotarget
Published: December 10, 2015
Last Updated: 09/26/2026